Targeting Thioredoxin Reductase 1 Reduction in Cancer Cells Inhibits Self-Sufficient Growth and DNA Replication
Min-Hyuk Yoo, Xue-Ming Xu, Bradley A. Carlson et al. · 2007
Read Targeting Thioredoxin Reductase 1 Reduction in Cancer Cells Inhibits Self-Sufficient Growth and DNA Replication by Min-Hyuk Yoo, Xue-Ming Xu, Bradley A. Carlson et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001112.txt.
Description
Min-Hyuk Yoo, Xue-Ming Xu, Bradley Carlson and colleagues showed that lowering a redox enzyme stalls cancer cell growth, in PLOS ONE in 2007. Thioredoxin reductase 1 is a major redox regulator and an antioxidant selenoprotein. It is thought to help prevent cancer, yet many cancer cells overproduce it, and numerous cancer drugs inhibit it.
The team targeted reduction of TR1 in cancer cells and report it inhibits self sufficient growth and DNA replication. A protein can guard normal cells and serve cancer at once; context decides. Cutting TR1 tests the cancer side of that bargain. The result supports TR1 as a drug target with a clear rationale.
Catalog record
| CREATOR | Min-Hyuk Yoo, Xue-Ming Xu, Bradley A. Carlson et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | Creative Commons CC0 License |
| RIGHTS | CC0 |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001112